These studies indicate that PEDF regulates genomic pathways which alter the expression of adhesion molecules and proteases, ultimately inhibiting anchorage-independent growth and invasion of BC cells into surrounding tissues or vessels at both the primary and secondary tumour sites. This evidence concerns the gene SERPINF1 and breast cancer.